BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23400387)

  • 1. Hematologic recovery after tandem high-dose chemotherapy and autologous stem cell transplantation in children with high-risk solid tumors.
    Son MH; Kim DH; Lee SH; Yoo KH; Sung KW; Koo HH; Kim JY; Cho EJ; Kang ES; Kim DW
    J Korean Med Sci; 2013 Feb; 28(2):220-6. PubMed ID: 23400387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron overload during follow-up after tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma.
    Bae SJ; Kang C; Sung KW; Chueh HW; Son MH; Lee SH; Yoo KH; Koo HH
    J Korean Med Sci; 2012 Apr; 27(4):363-9. PubMed ID: 22468098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system.
    Park ES; Sung KW; Baek HJ; Park KD; Park HJ; Won SC; Lim DH; Kim HS
    J Korean Med Sci; 2012 Feb; 27(2):135-40. PubMed ID: 22323859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function after tandem high-dose chemotherapy and autologous stem cell transplantation in children with Wilms tumor.
    Lee SH; Paik KH; Sung KW; Son MH; Yoo KH; Koo HH; Kim JY; Cho EJ
    Pediatr Transplant; 2011 Dec; 15(8):855-60. PubMed ID: 22060039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.
    Sung KW; Lim DH; Son MH; Lee SH; Yoo KH; Koo HH; Kim JH; Suh YL; Joung YS; Shin HJ
    Neuro Oncol; 2013 Mar; 15(3):352-9. PubMed ID: 23258845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.
    Baek HJ; Park HJ; Sung KW; Lee SH; Han JW; Koh KN; Im HJ; Kang HJ; Park KD
    J Neurooncol; 2013 Sep; 114(3):329-38. PubMed ID: 23824533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron chelation treatment with deferasirox prior to high-dose chemotherapy and autologous stem cell transplantation may reduce the risk of hepatic veno-occlusive disease in children with high-risk solid tumors.
    Chueh HW; Sung KW; Lee SH; Yoo KH; Koo HH; Kim JY; Cho EJ
    Pediatr Blood Cancer; 2012 Mar; 58(3):441-7. PubMed ID: 21638755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tandem high-dose chemotherapy and autologous stem cell transplantation for anaplastic ependymoma in children younger than 3 years of age.
    Sung KW; Lim DH; Lee SH; Yoo KH; Koo HH; Kim JH; Suh YL; Joung YS; Shin HJ
    J Neurooncol; 2012 Apr; 107(2):335-42. PubMed ID: 22081297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of tandem high-dose chemotherapy and autologous stem cell transplantation using carboplatin-thiotepa-etoposide and cyclophosphamide-melphalan regimens for malignant brain tumors in children and young adults.
    Lee SH; Son MH; Sung KW; Choi YB; Lee NH; Yoo KH; Koo HH; Lim DH; Shin HJ
    J Neurooncol; 2014 Dec; 120(3):507-13. PubMed ID: 25108776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of high-dose
    Lee JW; Lee S; Cho HW; Ma Y; Yoo KH; Sung KW; Koo HH; Cho EJ; Lee SK; Lim DH
    J Hematol Oncol; 2017 May; 10(1):108. PubMed ID: 28511709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Grade Gliomas in Children and Adolescents.
    Lee JW; Lim DH; Sung KW; Lee HJ; Yi ES; Yoo KH; Koo HH; Suh YL; Shin HJ
    J Korean Med Sci; 2017 Feb; 32(2):195-203. PubMed ID: 28049229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and effectiveness of treatment strategy of tandem high-dose chemotherapy and autologous stem cell transplantation in combination with
    Suh JK; Koh KN; Min SY; Kim YS; Kim H; Im HJ; Namgoong JM; Kim DY; Ahn SD; Lee JJ; Seo JJ
    Pediatr Transplant; 2020 Mar; 24(2):e13658. PubMed ID: 31960542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal treatment including tandem high-dose chemotherapy and autologous stem cell transplantation in children with anaplastic ependymomas.
    Lee JW; Lim DH; Sung KW; Lee HJ; Yi ES; Yoo KH; Koo HH; Suh YL; Shin HJ
    Pediatr Transplant; 2018 May; 22(3):e13127. PubMed ID: 29453811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk or Recurrent Bone and Soft Tissue Sarcomas.
    Choi YB; Yi ES; Lee JW; Yoo KH; Sung KW; Koo HH
    J Korean Med Sci; 2016 Jul; 31(7):1055-62. PubMed ID: 27366002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandem high-dose chemotherapy with autologous stem cell rescue for stage M high-risk neuroblastoma: Experience using melphalan/etoposide/carboplatin and busulfan/melphalan regimens.
    Kato S; Kubota Y; Watanabe K; Hogetsu K; Arakawa Y; Koh K; Takita J; Hiwatari M
    Pediatr Transplant; 2020 Nov; 24(7):e13772. PubMed ID: 32543778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis.
    Limvorapitak W; Barnett MJ; Hogge DE; Forrest DL; Nevill TJ; Narayanan S; Power MM; Nantel SH; Broady R; Song KW; Toze CL; Mourad YA; Sutherland HJ; Gerrie AS; White J; Sanford DS
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e481-e491. PubMed ID: 30100330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable hematopoietic recovery after peripheral blood stem cell transplantation in patients receiving high-dose chemotherapy for advanced germ cell tumors.
    Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M
    Anticancer Res; 2006; 26(6C):4965-8. PubMed ID: 17214371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center.
    Sung KW; Yoo KH; Chung EH; Cho EJ; Jung HL; Koo HH; Lee SK; Lim DH; Kim DY; Kim DW; Kim HR; Kim SW
    J Korean Med Sci; 2002 Aug; 17(4):537-43. PubMed ID: 12172052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.
    Sung KW; Son MH; Lee SH; Yoo KH; Koo HH; Kim JY; Cho EJ; Lee SK; Choi YS; Lim DH; Kim JS; Kim DW
    Bone Marrow Transplant; 2013 Jan; 48(1):68-73. PubMed ID: 22635247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
    Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
    Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.